About us Contacts Interactions: 118 620
Drug search by name

Antihemophilic Factor (Recombinant [Pegylated-aucl]) and Cardiovascular complications

Result of checking the interaction of drug Antihemophilic Factor (Recombinant [Pegylated-aucl]) and disease Cardiovascular complications for safety when used together.

Check result:
Antihemophilic Factor (Recombinant [Pegylated-aucl]) <> Cardiovascular complications
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Hemophilic patients with cardiovascular risk factors or diseases may be at the same risk to develop cardiovascular events as non-hemophilic patients when clotting has been normalized by treatment with factor VIII. Care should be exercised when using this agent in patients with cardiovascular risk factors.

Antihemophilic Factor (Recombinant [Pegylated-aucl])

Generic Name: antihemophilic factor

Brand Name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur

Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)

What is Antihemophilic Factor (Recombinant [Pegylated-aucl])?
Another drug Delete
The list of popular interactions
DiseDoc World
Interaction with food and lifestyle
  1. Antihemophilic Factor (Recombinant [Pegylated-aucl])
Drug interactions
  1. Antihemophilic Factor (Recombinant [Pegylated-aucl])
We use cookies to improve the site's performance. By continuing, you agree to use the cookies. OK